Literature DB >> 12960069

p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages.

Xiaotong Li1, Nobuyuki Udagawa, Masamichi Takami, Nobuaki Sato, Yasuhiro Kobayashi, Naoyuki Takahashi.   

Abstract

We previously reported that p38 MAPK signaling is required for osteoclast differentiation but not osteoclast function. Here we further investigated the role of p38 MAPK in the function and differentiation of mouse bone marrow macrophages (BMM phi), common precursors of osteoclasts and dendritic cells. Lipopolysaccharide (LPS) activated the p38 MAPK signaling pathway in BMM phi by sequential phosphorylation of MAPK kinase 3/6, p38 MAPK, and activating transcription factor-2. Treatment of BMM phi with SB203580, a p38 MAPK inhibitor, suppressed LPS-induced phosphorylation of activating transcription factor-2. LPS stimulated production of IL-1 beta, TNF alpha, and IL-6 in BMM phi, and SB203580 failed to inhibit the LPS-induced cytokine production. BMM phi incorporated latex beads via phagocytosis, and SB203580 had no effect on this phagocytosis. BMM phi differentiated into dendritic cells when treated with granulocyte macrophage colony-stimulating factor together with CD40 ligand, TNF alpha, or LPS, and SB203580 failed to inhibit this differentiation. Thus, p38 MAPK-mediated signals are not involved in either BMM phi function or BMM phi differentiation into dendritic cells. The differentiation of BMM phi into osteoclasts in response to receptor activator of nuclear factor-kappa B ligand or TNF alpha was strongly inhibited by SB203580. These findings emphasize the crucial roles of p38 MAPK-mediated signaling in osteoclast differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960069     DOI: 10.1210/en.2003-0166

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

1.  Over-expression of Sox2 in C3H10T1/2 cells inhibits osteoblast differentiation through Wnt and MAPK signalling pathways.

Authors:  Daofang Ding; Hao Xu; Qianqian Liang; Leqin Xu; Yongjian Zhao; Yongjun Wang
Journal:  Int Orthop       Date:  2011-10-20       Impact factor: 3.075

2.  Involvement of c-Abl, p53 and the MAP kinase JNK in the cell death program initiated in A2E-laden ARPE-19 cells by exposure to blue light.

Authors:  Barbro S Westlund; Bolin Cai; Jilin Zhou; Janet R Sparrow
Journal:  Apoptosis       Date:  2009-01       Impact factor: 4.677

3.  Establishment of optimized in vitro assay methods for evaluating osteocyte functions.

Authors:  Masashi Honma; Yuki Ikebuchi; Yoshiaki Kariya; Hiroshi Suzuki
Journal:  J Bone Miner Metab       Date:  2014-01-01       Impact factor: 2.626

4.  IL-1 mediates TNF-induced osteoclastogenesis.

Authors:  Shi Wei; Hideki Kitaura; Ping Zhou; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  Fibrodysplasia ossificans progressiva-related activated activin-like kinase signaling enhances osteoclast formation during heterotopic ossification in muscle tissues.

Authors:  Masato Yano; Naoyuki Kawao; Katsumi Okumoto; Yukinori Tamura; Kiyotaka Okada; Hiroshi Kaji
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

6.  The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.

Authors:  Kenta Watanabe; Michiko Hirata; Tsukasa Tominari; Chiho Matsumoto; Hidenori Fujita; Kazuhiko Yonekura; Gillian Murphy; Hideaki Nagase; Chisato Miyaura; Masaki Inada
Journal:  J Biol Chem       Date:  2016-08-18       Impact factor: 5.157

7.  Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice.

Authors:  Naoyuki Kawao; Masato Yano; Yukinori Tamura; Katsumi Okumoto; Kiyotaka Okada; Hiroshi Kaji
Journal:  J Bone Miner Metab       Date:  2015-07-24       Impact factor: 2.626

8.  Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.

Authors:  Angela Pennisi; Xin Li; Wen Ling; Sharmin Khan; Dana Gaddy; Larry J Suva; Bart Barlogie; John D Shaughnessy; Nazneen Aziz; Shmuel Yaccoby
Journal:  Br J Haematol       Date:  2009-04-08       Impact factor: 6.998

9.  Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners.

Authors:  Masahiro Takahashi; Toshihide Mizoguchi; Shunsuke Uehara; Yuko Nakamichi; Shuhua Yang; Hiroko Naramoto; Teruhito Yamashita; Yasuhiro Kobayashi; Minoru Yamaoka; Kiyofumi Furusawa; Nobuyuki Udagawa; Takashi Uematsu; Naoyuki Takahashi
Journal:  J Bone Miner Metab       Date:  2008-12-13       Impact factor: 2.626

10.  Stimulation of macrophage TNFalpha production by orthopaedic wear particles requires activation of the ERK1/2/Egr-1 and NF-kappaB pathways but is independent of p38 and JNK.

Authors:  Michelle A Beidelschies; Honglian Huang; Megan R McMullen; Matthew V Smith; Andrew S Islam; Victor M Goldberg; Xin Chen; Laura E Nagy; Edward M Greenfield
Journal:  J Cell Physiol       Date:  2008-12       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.